130 related articles for article (PubMed ID: 25104196)
21. The role of positron emission tomography (PET) in the management of cervical lymph nodes metastases from an unknown primary tumour.
Mevio E; Gorini E; Sbrocca M; Artesi L; Mullace M; Caimi F
Acta Otorhinolaryngol Ital; 2004 Dec; 24(6):342-7. PubMed ID: 15952684
[TBL] [Abstract][Full Text] [Related]
22. Utility of panendoscopy for the detection of unknown primary head and neck cancer in patients with a negative PET/CT scan.
Pattani KM; Goodier M; Lilien D; Kupferman T; Caldito G; Nathan CO
Ear Nose Throat J; 2011 Aug; 90(8):E16-20. PubMed ID: 21853427
[TBL] [Abstract][Full Text] [Related]
23. In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT.
Wartski M; Le Stanc E; Gontier E; Vilain D; Banal A; Tainturier C; Pecking AP; Alberini JL
Nucl Med Commun; 2007 May; 28(5):365-71. PubMed ID: 17414886
[TBL] [Abstract][Full Text] [Related]
24. Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.
Gourin CG; Watts TL; Williams HT; Patel VS; Bilodeau PA; Coleman TA
Laryngoscope; 2008 Apr; 118(4):671-5. PubMed ID: 18197136
[TBL] [Abstract][Full Text] [Related]
25. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.
Gourin CG; Boyce BJ; Williams HT; Herdman AV; Bilodeau PA; Coleman TA
Laryngoscope; 2009 Nov; 119(11):2150-5. PubMed ID: 19544378
[TBL] [Abstract][Full Text] [Related]
26. The impact of FDG PET on the management of occult primary head and neck tumours.
Wong WL; Saunders M
Clin Oncol (R Coll Radiol); 2003 Dec; 15(8):461-6. PubMed ID: 14690001
[TBL] [Abstract][Full Text] [Related]
27. Positron emission tomography (PET) in the staging of head neck cancer: comparison between PET and CT.
Bruschini P; Giorgetti A; Bruschini L; Nacci A; Volterrani D; Cosottini M; Ursino F; Mariani G; Fattori B
Acta Otorhinolaryngol Ital; 2003 Dec; 23(6):446-53. PubMed ID: 15198047
[TBL] [Abstract][Full Text] [Related]
28. The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care.
Gordin A; Golz A; Keidar Z; Daitzchman M; Bar-Shalom R; Israel O
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):130-7. PubMed ID: 17599580
[TBL] [Abstract][Full Text] [Related]
29. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501
[TBL] [Abstract][Full Text] [Related]
30. Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.
Deron PB; Bonte KM; Vermeersch HF; Van de Wiele C
Cancer Biother Radiopharm; 2011 Jun; 26(3):331-4. PubMed ID: 21711095
[TBL] [Abstract][Full Text] [Related]
31. Combination of panendoscopy and positron emission tomography/computed tomography increases detection of unknown primary head and neck carcinoma.
Sokoya M; Chowdhury F; Kadakia S; Ducic Y
Laryngoscope; 2018 Nov; 128(11):2573-2575. PubMed ID: 30194842
[TBL] [Abstract][Full Text] [Related]
32. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
Basu D; Siegel BA; McDonald DJ; Nussenbaum B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
[TBL] [Abstract][Full Text] [Related]
33. The role of tonsillectomy in the initial diagnostic work-up of head and neck squamous cell carcinoma of unknown primary.
Berta E; Atallah I; Reyt E; Boyer E; Karkas A; Righini CA
Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Nov; 131(5):305-8. PubMed ID: 25443689
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic work-up and outcome of cervical metastases from an unknown primary.
Guntinas-Lichius O; Peter Klussmann J; Dinh S; Dinh M; Schmidt M; Semrau R; Mueller RP
Acta Otolaryngol; 2006 May; 126(5):536-44. PubMed ID: 16698706
[TBL] [Abstract][Full Text] [Related]
35. FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary.
Paul SA; Stoeckli SJ; von Schulthess GK; Goerres GW
Eur Arch Otorhinolaryngol; 2007 Feb; 264(2):189-95. PubMed ID: 17177026
[TBL] [Abstract][Full Text] [Related]
36. Combined [18F]fluorodeoxyglucose positron emission tomography and computed tomography for detecting contralateral neck metastases in patients with head and neck squamous cell carcinoma.
Kim SY; Kim JS; Doo H; Lee H; Lee JH; Cho KJ; Choi SH; Nam SY; Roh JL
Oral Oncol; 2011 May; 47(5):376-80. PubMed ID: 21470899
[TBL] [Abstract][Full Text] [Related]
37. [Significance of PET and integrated PET/CT in the diagnostics of occult primary tumors].
Schneider K; Hrasky A; Aschoff P; Bihl H; Hagen R
Laryngorhinootologie; 2006 Nov; 85(11):819-23. PubMed ID: 16612756
[TBL] [Abstract][Full Text] [Related]
38. Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer.
Xu N; Wang M; Zhu Z; Zhang Y; Jiao Y; Fang W
Chin Med J (Engl); 2014; 127(4):607-13. PubMed ID: 24534208
[TBL] [Abstract][Full Text] [Related]
39. Limitations of PET/CT in determining need for neck dissection after primary chemoradiation for advanced head and neck squamous cell carcinoma.
Lyford-Pike S; Ha PK; Jacene HA; Saunders JR; Tufano RP
ORL J Otorhinolaryngol Relat Spec; 2009; 71(5):251-6. PubMed ID: 19776658
[TBL] [Abstract][Full Text] [Related]
40. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.
Schöder H; Carlson DL; Kraus DH; Stambuk HE; Gönen M; Erdi YE; Yeung HW; Huvos AG; Shah JP; Larson SM; Wong RJ
J Nucl Med; 2006 May; 47(5):755-62. PubMed ID: 16644744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
